Catherine Friedman
Board Member
Lyell Immunopharma, Inc. (LYEL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Catherine Friedman
Catherine Friedman is recorded as Board Member at Lyell Immunopharma, Inc. (LYEL). Earlier roles on record: Board Member at Seer, Inc. (SEER) until December 21, 2023. Seer, Inc. reported in an 8-K filed December 22, 2023 that Catherine Friedman resigned as member of the Company's Board of Directors, effective December 21, 2023.
“On December 21, 2023, Catherine Friedman informed Seer, Inc. (the "Company") of her resignation as a member of the Company's Board of Directors (the "Board") and all committees thereof, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2018-01-01–present
-
2020-01-01–2023-12-21
-
2020-01-01–2023-12-21
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lyell Immunopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Lynn Seely CEO, Board Member
- Cathy Friedman Chairman
- Lynn Seely, M.D. CFO
- Smital Shah CFO
- Stephen Hill COO
- Richard Goold CIO
- Mark Meltz General Counsel
- Veronica Sanchez Bulis Chief Accounting Officer
- Elizabeth Nabel Board Member
- Mark Bachleda Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.